Anna Borowiec
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Environmental endocrine disruptors in cardio-oncology: emerging modifiers of cardiovascular vulnerability in patients with cancer.
Journal: Cardio-oncology (London, England)
Published: June 03, 2026
Editorial: Cardiomyopathy and heart failure in oncology.
Journal: Frontiers in oncology
Published: March 12, 2026
Dynamics of HER2 status following neoadjuvant systemic therapy in breast cancer: a large single-center cohort analysis.
Journal: Therapeutic advances in medical oncology
Published: December 23, 2025
Predictive Value of Baseline Left Ventricular Global Longitudinal Strain for Cardiac Dysfunction in Patients with Moderate to High Risk of Cancer Therapy-Related Cardiovascular Toxicity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 22, 2025
Coronary Artery Calcium Score as a Predictor of Anthracycline-Induced Cardiotoxicity: The ANTEC Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 17, 2025
Potential New Applications of Sodium-Glucose Cotransporter-2 Inhibitors Across the Continuum of Cancer-Related Cardiovascular Toxicity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 18, 2025
Interleukin-6 in Anthracycline-Related Cardiac Dysfunction: A Comparison with Myeloperoxidase and TNF-Alpha.
Journal: International journal of molecular sciences
Published: March 17, 2025
Neurofilaments as Prognostic Biomarkers in the Assessment of the Risk of Advanced Taxane-Induced Neuropathy in Breast Cancer Patients-A Pilot Study.
Journal: Cancers
Published: January 28, 2025
Coronary artery calcium score and other risk factors in patients at moderate and high risk of cancer therapy-related cardiovascular toxicity.
Journal: Cardio-oncology (London, England)
Published: July 23, 2024
Sodium-Glucose Cotransporter 2 Inhibitors During Cancer Therapy: Benefits, Risks, and Ongoing Clinical Trials.
Journal: Current oncology reports
Published: July 02, 2024
Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
Journal: PloS one
Published: November 09, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026